198 related articles for article (PubMed ID: 7252264)
1. Duration of infection-derived immunity to cholera.
Levine MM; Black RE; Clements ML; Cisneros L; Nalin DR; Young CR
J Infect Dis; 1981 Jun; 143(6):818-20. PubMed ID: 7252264
[TBL] [Abstract][Full Text] [Related]
2. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
[TBL] [Abstract][Full Text] [Related]
3. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
Clements ML; Levine MM; Young CR; Black RE; Lim YL; Robins-Browne RM; Craig JP
J Infect Dis; 1982 Apr; 145(4):465-73. PubMed ID: 7069227
[TBL] [Abstract][Full Text] [Related]
4. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
Lycke N; Svennerholm AM; Holmgren J
Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
[TBL] [Abstract][Full Text] [Related]
5. Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease.
Jertborn M; Svennerholm AM; Holmgren J
J Clin Microbiol; 1986 Aug; 24(2):203-9. PubMed ID: 3528211
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection.
Glass RI; Svennerholm AM; Khan MR; Huda S; Huq MI; Holmgren J
J Infect Dis; 1985 Feb; 151(2):236-42. PubMed ID: 3968450
[TBL] [Abstract][Full Text] [Related]
8. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
Sinha VB; Bhaskaran K
Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
[TBL] [Abstract][Full Text] [Related]
9. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial and antitoxin responses in the serum and milk of cholera patients.
Majumdar AS; Dutta P; Dutta D; Ghose AC
Infect Immun; 1981 Apr; 32(1):1-8. PubMed ID: 7216479
[TBL] [Abstract][Full Text] [Related]
11. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
Levine MM; Black RE; Clements ML; Cisneros L; Saah A; Nalin DR; Gill DM; Craig JP; Young CR; Ristaino P
J Infect Dis; 1982 Mar; 145(3):296-9. PubMed ID: 7061878
[TBL] [Abstract][Full Text] [Related]
12. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
Snyder JD; Allegra DT; Levine MM; Craig JP; Feeley JC; DeWitt WE; Blake PA
J Infect Dis; 1981 Feb; 143(2):182-7. PubMed ID: 7194358
[TBL] [Abstract][Full Text] [Related]
13. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
[TBL] [Abstract][Full Text] [Related]
14. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Levine MM; Nalin DR; Craig JP; Hoover D; Bergquist EJ; Waterman D; Holley HP; Hornick RB; Pierce NP; Libonati JP
Trans R Soc Trop Med Hyg; 1979; 73(1):3-9. PubMed ID: 442179
[TBL] [Abstract][Full Text] [Related]
15. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
[TBL] [Abstract][Full Text] [Related]
16. Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
Harris JR; Holmberg SD; Parker RD; Kay DE; Barrett TJ; Young CR; Levine MM; Blake PA
Am J Epidemiol; 1986 Mar; 123(3):424-30. PubMed ID: 3946388
[TBL] [Abstract][Full Text] [Related]
17. Impaired immune response to natural infection as a correlate of vaccine failure in a field trial of killed oral cholera vaccines.
Clemens J; Rao M; Sack D; Ahmed F; Khan MR; Chakraborty J; Kay B; Huda S; Yunus M; van Loon F
Am J Epidemiol; 1995 Oct; 142(7):759-64. PubMed ID: 7572947
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
[TBL] [Abstract][Full Text] [Related]
19. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
[TBL] [Abstract][Full Text] [Related]
20. [The use of immunoenzyme analysis and the vibriocidal antibody reaction in the serological examination of persons who have had cholera and of those in contact with them].
Mareev VI; Moskvitina EA; Gritsenko AN; Ivanova LV; Efanova EA; Nepomniashchaia NB; Dranov IIu; Boldyr' LA; Griseva LN
Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):34-6. PubMed ID: 1867031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
